Turnitin
降AI改写
早检测系统
早降重系统
Turnitin-UK版
万方检测-期刊版
维普编辑部版
Grammarly检测
Paperpass检测
checkpass检测
PaperYY检测
Potential SARS-CoV-2 main protease inhibitors
Highlights•The SARS-CoV-2 main protease is a prime drug target.•Coronavirus main
proteases share a structurally conserved substrate-binding region.•The structure and …
proteases share a structurally conserved substrate-binding region.•The structure and …
A review on drug repurposing applicable to COVID-19
Drug repurposing involves the identification of new applications for existing drugs at a lower
cost and in a shorter time. There are different computational drug-repurposing strategies and …
cost and in a shorter time. There are different computational drug-repurposing strategies and …
Exploration of natural compounds with anti-SARS-CoV-2 activity via inhibition of SARS-CoV-2 Mpro
Abstract Coronavirus disease 2019 (COVID-19), caused by severe acute respiratory
syndrome coronavirus 2 (SARS-CoV-2), is a dreaded pandemic in lack of specific …
syndrome coronavirus 2 (SARS-CoV-2), is a dreaded pandemic in lack of specific …
Automated discovery of noncovalent inhibitors of SARS-CoV-2 main protease by consensus Deep Docking of 40 billion small molecules
Recent explosive growth of 'make-on-demand'chemical libraries brought unprecedented
opportunities but also significant challenges to the field of computer-aided drug discovery …
opportunities but also significant challenges to the field of computer-aided drug discovery …
Therapeutic potentials of antiviral plants used in traditional African medicine with COVID-19 in focus: A Nigerian perspective
The coronavirus disease 2019 (COVID-19) pandemic is caused by an infectious novel strain
of coronavirus known as severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) …
of coronavirus known as severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) …
Screening of phytochemicals as potent inhibitor of 3-chymotrypsin and papain-like proteases of SARS-CoV2: an in silico approach to combat COVID-19
COVID-19 and its causative organism SARS-CoV2 that emerged from Wuhan city, China
have paralyzed the world. With no clinically approved drugs, the global health system is …
have paralyzed the world. With no clinically approved drugs, the global health system is …
A multi-pronged approach targeting SARS-CoV-2 proteins using ultra-large virtual screening
The unparalleled global effort to combat the continuing severe acute respiratory syndrome
coronavirus 2 (SARS-CoV-2) pandemic over the last year has resulted in promising …
coronavirus 2 (SARS-CoV-2) pandemic over the last year has resulted in promising …
Allosteric binding sites of the SARS-CoV-2 main protease: Potential targets for broad-spectrum anti-coronavirus agents
The current pandemic caused by the COVID-19 disease has reached everywhere in the
world and has affected every aspect of our lives. As of the current data, the World Health …
world and has affected every aspect of our lives. As of the current data, the World Health …
[HTML][HTML] In silico identification of potential natural product inhibitors of human proteases key to SARS-CoV-2 infection
Presently, there are no approved drugs or vaccines to treat COVID-19, which has spread to
over 200 countries and at the time of writing was responsible for over 650,000 deaths …
over 200 countries and at the time of writing was responsible for over 650,000 deaths …
[HTML][HTML] GC-MS, LC-MS/MS, docking and molecular dynamics approaches to identify potential SARS-CoV-2 3-chymotrypsin-like protease inhibitors from Zingiber …
This study aims to identify and isolate the secondary metabolites of Zingiber officinale using
GC-MS, preparative TLC, and LC-MS/MS methods, to evaluate the inhibitory potency on …
GC-MS, preparative TLC, and LC-MS/MS methods, to evaluate the inhibitory potency on …